BJMO - volume 17, issue 4, june 2023
W. Lybaert MD, T. Vandamme MD, PhD, L. Mariën MSc, O. Islam MD, S. Chhajlani MD, I. Van der Massen MSc, N. Ahmadi Bidakhvidi MD, C.M. Deroose MD, PhD
The 2023 edition of the European Neuroendocrine Tumour Society (ENETS) congress was held in Vienna between 22nd and 24th March. This article aims to provide an overview of the most remarkable findings and insights presented during this congress.
(BELG J MED ONCOL 2023;17(4):139–49)
Read moreBJMO - volume 16, issue 8, december 2022
B. Geerinckx MD, C. Lambrechts MD, H. Oliveres , H. Prenen MD, PhD, T. Vandamme MD, PhD
The European Society of Medical Oncology (ESMO) Congress 2022 was held in Paris, France, between the 9th and 13th of September 2022. The main goal of this overview is to highlight the most relevant findings in the field of digestive oncology that could impact daily clinical practice. First, the upper gastrointestinal tract tumours will be discussed, followed by an overview of the congress highlights related to cancers of the lower gastrointestinal tract.
(Belg J Med Oncol 2022;16(8):412–20)
Read moreBJMO - volume 16, issue 6, october 2022
W. Lybaert MD, T. Vandamme MD, PhD, L. Mariën MSc, O. Islam MD, I. Van der Massen MSc, I. Karfis MD, PhD, H. Eggers , M. Peeters MD, PhD
The first World NET Forum brought together leading scientists in the neuroendocrine tumour (NET) field to present their cutting-edge research to inspire other scientists and clinicians. This meeting focused mainly on models in NET research, NET tumour biology, as well as therapeutic and diagnostic advances. This article discusses some of the most relevant and promising studies.
(BELG J MED ONCOL 2022;16(6):310–22)
Read moreBJMO - volume 16, issue 5, september 2022
H. Oliveres , T. Vandamme MD, PhD, H. Prenen MD, PhD
The 2022 ASCO Annual Meeting was held in Chicago, USA, between the 3rd and 7th of June 2022. The main goal of this overview is to highlight the most striking abstracts in the field of digestive oncology for daily clinical practice. First, the upper gastro-intestinal tract tumours will be discussed, followed by an overview of the congress highlights related to cancers of the lower gastro-intestinal tract.
(Belg J Med Oncol 2022;16(5):223–8)
Read moreBJMO - volume 16, issue 2, march 2022
D. Naudts MD, L-A. Teuwen MD, J. Van Boven , H. Prenen MD, PhD, T. Vandamme MD, PhD, B. Van Overberghe MD, K. Forceville MD, M. Peeters MD, PhD
5-Fluorouracil (5-FU) and its prodrug capecitabine are widely used and generally well-tolerated chemotherapeutic agents. Although leucovorin, a derivative of folic acid, is routinely used to potentiate the effect of 5-FU, there seems to be little to no awareness about a similar interplay between capecitabine and folic acid, a commonly used supplement. This study presents a case in which a high concentration of folic acid led to fatal capecitabine-related toxicity, with the aim to raise awareness on the interaction between folic acid supplementation and 5-FU/capecitabine treatment toxicity.
(BELG J MED ONCOL 2022;16(2):74–8)
Read moreBJMO - volume 15, issue 8, december 2021
H. Dedecker MD, L-A. Teuwen MD, T. Vandamme MD, PhD, H. Prenen MD, PhD, M. Peeters MD, PhD
The 2021 edition of ESMO was held virtually between the 16th and 21st of September 2021. The main goal of this overview is to highlight the most striking abstracts in the field of digestive oncology for daily clinical practice. First, the upper gastro-intestinal tract tumours will be discussed, followed by an overview of the congress highlights related to cancers of the lower gastro-intestinal tract.
(BELG J MED ONCOL 2021;15(5):415–20)
Read moreBJMO - volume 14, issue 8, december 2020
L-A. Teuwen MD, M. Peeters MD, PhD, T. Vandamme MD, PhD, H. Prenen MD, PhD
The annual ESMO meeting was held virtually between 19th and 21st September 2020 and covered many interesting abstracts in the field of digestive oncology. In this overview, our main aim was to highlight the data that are most relevant for daily clinical practice. This year, we will discuss the results according to the traditional division in upper and lower gastro-intestinal tract tumours.
Read more